top of page

March 5, 2026

Interview with a Cardiologist with Expertise in Echocardiography

  • 5 days ago
  • 3 min read

We recently spoke with a leading cardiologist specializing in echocardiography and hypertrophic cardiomyopathy (HCM), whose clinical work focuses on caring for adults with this complex genetic heart condition and whose research focuses on advancing risk prediction and early diagnosis through advanced imaging and computational analysis. His perspective highlights how emerging wearable and remote ultrasound technologies could significantly expand access to cardiac imaging, improve early detection, and enable more precise, continuous monitoring of heart health.


Expanding access to cardiac imaging


Despite the central role of echocardiography in diagnosing structural heart disease, access remains constrained by infrastructure and expertise. Traditional echo requires specialized equipment, dedicated imaging suites, and highly trained technicians and physicians to acquire and interpret the images. As a result, even though echocardiography is more widely available than other imaging modalities, it remains a relatively scarce clinical resource.


This limitation creates barriers for both patients and providers. Individuals may face delays or geographic obstacles in obtaining imaging, while clinicians must balance demand against limited imaging capacity. For patients with conditions like hypertrophic cardiomyopathy, where early diagnosis and ongoing monitoring are critical, these access gaps can delay intervention and worsen outcomes.


Remote imaging technologies offer a compelling solution. The ability to acquire cardiac ultrasound data outside of traditional hospital settings and transmit it electronically to expert readers or AI-enabled interpretation systems could dramatically expand availability. By bringing imaging directly to patients, clinicians can evaluate heart structure and function earlier and more frequently, improving diagnostic accuracy and continuity of care.


Enabling large-scale screening and earlier detection


One of the most significant opportunities for wearable cardiac ultrasound lies in population-level screening. Many individuals at risk for structural heart disease remain undiagnosed, particularly those without ready access to specialty care or imaging facilities. Wearable ultrasound patches could be distributed directly to patients, allowing them to collect cardiac data at home and transmit it for clinical interpretation.


This approach could transform how structural heart disease is detected. Early identification of abnormalities, such as thickening of the heart muscle, chamber dilation, or valve dysfunction, enables clinicians to intervene sooner with therapies that improve long-term outcomes and quality of life. For conditions like hypertrophic cardiomyopathy, where early recognition can help prevent complications including arrhythmias or sudden cardiac events, timely imaging is especially valuable.


By expanding access beyond hospital walls, wearable ultrasound technologies have the potential to identify disease earlier, when intervention is most effective.


Supporting patients beyond the clinic


Wearable cardiac ultrasound also offers meaningful benefits for patients already diagnosed with cardiovascular conditions. For individuals discharged after hospitalization or evaluated in a clinic for ongoing cardiac concerns, continuous or periodic monitoring at home provides clinicians with critical information to guide treatment decisions.


In this scenario, patients could be sent home with a wearable ultrasound patch that collects cardiac imaging data and transmits it remotely. This enables clinicians to monitor parameters such as heart function, chamber size, or intracardiac pressures without requiring the patient to return for frequent in-person imaging appointments.


This model supports more proactive care. By identifying subtle changes earlier, physicians can adjust medications or treatment plans before symptoms worsen or hospitalization becomes necessary. In addition to improving clinical outcomes, this approach reduces patient burden and improves overall care efficiency.


Designing the ideal wearable cardiac ultrasound


From a clinical perspective, the ideal wearable cardiac ultrasound would combine simplicity, affordability, and scalability. A small, lightweight device, potentially no larger than a credit card, could be deployed directly to patients or through healthcare providers, enabling imaging outside traditional clinical environments.


Cost is also a critical factor. Low-cost devices could be deployed at scale, making cardiac imaging accessible to broader populations without straining healthcare budgets. Reusability and minimal infrastructure requirements, such as independence from continuous AC power, would further enhance scalability and usability.


These features would allow cardiac imaging to move beyond centralized facilities and into patients’ homes, communities, and remote settings, bringing diagnostic capability directly to those who need it most.


Advancing precision cardiology and democratizing heart health


Ultimately, wearable cardiac ultrasound represents a powerful step toward democratizing access to cardiovascular care. Remote imaging technologies enable reliable data acquisition in underserved and rural communities, where access to specialized cardiac imaging and expert interpretation may be limited.


Earlier detection, continuous monitoring, and broader access to imaging can improve risk prediction, guide treatment decisions, and prevent adverse outcomes.


By extending the reach of advanced cardiac imaging beyond traditional clinical settings, wearable ultrasound technologies have the potential to transform how heart disease is detected, monitored, and managed, making high-quality cardiac care more accessible, proactive, and precise for patients everywhere.




 
 
bottom of page